The next-generation platform provides reconciliation of medication activity supporting faster, more informed decision-making for patient safety
CHESHIRE, Conn., Dec. 5, 2022 /PRNewswire/ -- Medacist, the industry leader in drug diversion technology solutions, today introduced RxAuditor Reconcile, a new addition to the company's extensive product portfolio, designed to provide users the capability to close the loop on the medication use process and quickly identify anomalous activity in real time.
Built on the firm's 24 years of industry-specific data, RxAuditor Reconcile supports RxAuditor Investigate to help healthcare professionals streamline and accelerate drug diversion investigations with actionable information. Powered by Medacist's Genesis™ platform, the drug analytics solution leverages artificial intelligence and machine learning to provide organizations with standardized, collaborative workflows for drug diversion activities.
"Medacist's RxAuditor Reconcile delivers a simpler, faster, and more cost-effective solution for accountability in healthcare facilities," said David J. Brzozowski Jr., CTO, Medacist. "The addition of this new product to our portfolio provides our customers with a powerful drug diversion detection solution that enhances medication observability by monitoring the entire drug chain of custody." Read More >>
